Bococizumab is a cutting-edge anti-PCSK9 antibody effectively developed to treat hypercholesterolemia. Such therapeutic agent interacts with the PCSK9 protein, a key regulator of cholesterol levels. By blocking the https://dirstop.com/story27951179/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia